bpi glp-1 labs is challenging the tirzepatide patent. This is a second challenge as Empower pharmacy was already challenging the patent. BPI includes additional imformation including a previous patent application showing GLP-1/GIP as ONE + Receptor Activator features two clinically validated botanical ingredients Personalized GLP-1 Injection

By providing a reliable and efficient means to verify GLP-1 patient status, VerifyPass helps bridge the gap between GLP-1 patients and the services that cater specifically to their condition, ultimately contributing to a more connected and supportive healthcare ecosystem.

Single ingredient : hydrolyzed bovine collagen (Type I and Type III peptides)

Medication Disposal Do not flush semaglutide down the toilet unless the specific pharmacy instructions tell you to do so

The online conversation around these drugs mirrors what I have seen for years in menopause care: skepticism, shame, misinformation, and gatekeeping

References & Resources Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute medical advice

2.4 Wisconsin Pharmacal Company LLC Date of Issuance: August 22, 2025 Location: Jackson, Wisconsin, United States Product Type: Finished Pharmaceuticals (OTC) The inspection of Wisconsin Pharmacal Company LLC focused heavily on the specific configuration of Liquid Chromatography (LC) and Gas Chromatography (GC) instruments